Hydra: an autonomous discovery engine for life science
Research that took a team weeks now runs from a single prompt, validated and self-corrected, in hours.
Use the platform, or have us build for you
Accelerate your research with Hydra today, or have us build and deploy custom AI to improve how your team works.
Hydra, the self-serve platform
“You already know the biology. Stop waiting on the analysis.”
Built for scientists who have the data but don't want to code or wait weeks for a report. Bring your data and your question. Hydra plans the analysis, runs it, and validates the result.
- No code, nothing to set up
- Answers in hours, not weeks
- Scientific validation built in
Custom AI workflows and enterprise deployment
“Your data is your edge. We make it compound.”
For biotech and pharma teams. We build custom AI workflows around your proprietary data and deploy them securely in your environment, so your science becomes a lasting advantage.
- Custom workflows on your data
- Secure deployment in your environment
- Data and AI strategy
Most AI tools must be hand-steered. Hydra runs itself.
Other tools chat until you steer them to a conclusion. Hydra is built for autonomous execution, wrapped in a planning-and-validation layer that enforces scientific scrutiny while adapting to your team. It doesn't just respond. It plans, executes, and validates.
Plans
Hydra decomposes your question into a rigorous analysis plan, choosing the right datasets, methods, and controls before a single line runs.
Executes
It runs the analysis autonomously across ~100 preloaded databases and 200+ codified skills. No pipelines to wire, nothing to babysit.
Validates
A planning-and-validation layer scrutinizes every result for scientific rigor, surfacing assumptions, caveats, and confidence, not just an answer.
Plans, executes, validates. Not just chats.
See what it can answer →The knowledge of a bioinformatics team, on tap
Breadth without the busywork. Hydra ships with the data and the know-how already inside, so analysis starts from rigor, not setup.
DepMap, TCGA, cBioPortal, and more, preloaded
How bioinformatic analysis should actually be done
Oncology, genomics, proteomics, clinical & beyond
Planning & scrutiny wrapped around every run
Preloaded sources include
Ask the questions you'd ask a bioinformatics team
Each card opens a full case study: the problem, how Hydra solved it, and the data behind it.
Your data is your edge. We make it compound.
We partner with SMB biotechs and pharma teams to build custom AI that turns proprietary science into a self-improving competitive moat that strengthens with every experiment.
Custom AI workflows
Custom agents that run your science the way your team actually runs it, on your proprietary data.
Data & AI strategy
Where your data creates leverage, what to build first, and how to compound it over time.
Bespoke development
From proof-of-concept to production, squeezing maximum insight out of the science only you have.
The compounding moat
Every data type connects. Tap a node to see how Hydra integrates your omics into one compounding edge.
Scientists and builders, aligned
A team that has worked with large language models since their earliest days, backed by scientific and business leaders from Harvard, MIT, and DTU.
Bogumil Zimon
CEO & Co-Founder · MSc
5+ years building software for pharma and biotech, including Proteon Pharmaceuticals, Cirqle Biomedical, and Visiopharm. Secured PharosBio's first funding, pilots, and paying customers.
LinkedIn
Aurel Prosz
CTO & Co-Founder · PhD
Academic leader with start-up experience, specialised in data analysis and machine learning in oncology through doctoral studies at the Danish Cancer Institute. Helped build one of the first AI drug-discovery companies.
LinkedInAdvisory board
Zoltan Szallasi
Scientific Advisor · PhD
- Assistant Professor, Harvard Medical School
- Cancer research leader in computational oncology
Frederik Madsen
Business Advisor · MBA
- CEO of June
- Serial entrepreneur who has built, scaled, and exited biotech companies
Thomas Crouzier
Scientific Advisor · PhD
- CSO of June
- Breakthrough researcher at MIT and DTU
Building with world-class institutions
From raw data to publication, we collaborate with leading research institutes and labs, and we're backed by commercial and institutional investors.
Research partners
Backed by leading investors
